Advancing Longevity Trials: Lessons from mTOR-Targeting Interventions
What two decades of trials can teach us about translating rapamycin to human aging.
Longevity Industrialized
News, thoughts, and analyses on longevity, focused on what is driving and limiting progress towards human impact. Writings from Martin Borch Jensen and other members/affiliates of Norn Group.
Recommendations
Alex Kesin
Jason Crawford
Elliot Hershberg
Ruxandra Teslo
Norn Group resources